Literature DB >> 17388734

Modifiable risk factors for breast cancer recurrence: what can we tell survivors?

Sandra A Norman1, Sheryl L Potashnik, Mary Lou Galantino, Angela M De Michele, Lauren House, A Russell Localio.   

Abstract

The potential for recurrence causes considerable distress for breast cancer survivors. Major information sources for survivors and providers offer few clear recommendations for postdiagnosis lifestyle change related to recurrence. To design interventions to improve long-term survivors' care and quality of life, we must know what survivors are doing to prevent recurrence in the absence of solid evidence, whether survivors' perceptions and behaviors correspond to hypothesized modifiable risk factors for recurrence, and whether survivors are adopting behaviors that could otherwise be harmful to their health. Our review first addresses the general lack of consensus on the impact of specific lifestyle factors on breast cancer recurrence and the resulting equivocal lifestyle recommendations for survivors. Second, we describe inadequacies of the studies of survivors' lifestyle changes related to recurrence. Because much of the existing knowledge about modifiable risk factors for recurrence comes from studies of survivors whose participation and behavior change were potentially influenced by their concern about recurrence, we need large, population-based observational studies of randomly selected breast cancer survivors, adequately representing the target population. Critical are data on lifestyle change from prediagnosis to postdiagnosis and changes over time after diagnosis, extensive data on conventional and nonconventional treatments, and the temporal relationship between behaviors and treatments, and inclusion of the full complement of potential lifestyle risk factors for recurrence. Understanding in detail the current status of survivors' perceptions and behaviors related to modifiable risk factors for recurrence can provide considerable practical information to inform future interventions and communication strategies for breast cancer survivors.

Entities:  

Mesh:

Year:  2007        PMID: 17388734     DOI: 10.1089/jwh.2006.0047

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  12 in total

1.  Racial and ethnic differences in health status and health behavior among breast cancer survivors--Behavioral Risk Factor Surveillance System, 2009.

Authors:  Arica White; Lori A Pollack; Judith Lee Smith; Trevor Thompson; J Michael Underwood; Temeika Fairley
Journal:  J Cancer Surviv       Date:  2012-12-05       Impact factor: 4.442

2.  Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Hazel B Nichols; John M Hampton; Polly A Newcomb
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

3.  The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics.

Authors:  Sarah J Nechuta; Bette J Caan; Wendy Y Chen; Shirley W Flatt; Wei Lu; Ruth E Patterson; Elizabeth M Poole; Marilyn L Kwan; Zhi Chen; Erin Weltzien; John P Pierce; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2011-06-28       Impact factor: 2.506

4.  Assessing Physical Activity Behavior of Cancer Survivors by Race and Social Determinants of Health.

Authors:  Matthew Asare; Scott McIntosh; Eva Culakova; Amina Alio; M Renee Umstattd Meyer; Amber S Kleckner; Georges Adunlin; Ian R Kleckner; Kelly R Ylitalo; Charles S Kamen
Journal:  Int Q Community Health Educ       Date:  2019-06-26

Review 5.  The expanding use of third-generation aromatase inhibitors: what the general internist needs to know.

Authors:  Susan Hong; Aarati Didwania; Olufunmilayo Olopade; Pamela Ganschow
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

6.  Well-being of newly diagnosed women with breast cancer: which factors matter more?

Authors:  Rugilė Ivanauskienė; Žilvinas Padaiga; Renata Šimoliūnienė; Giedrė Smailytė; Auksė Domeikienė
Journal:  Support Care Cancer       Date:  2013-10-18       Impact factor: 3.603

7.  Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.

Authors:  Dora Romaguera; Heather Ward; Petra A Wark; Anne-Claire Vergnaud; Petra H Peeters; Carla H van Gils; Pietro Ferrari; Veronika Fedirko; Mazda Jenab; Marie-Christine Boutron-Ruault; Laure Dossus; Laureen Dartois; Camilla Plambeck Hansen; Christina Catherine Dahm; Genevieve Buckland; María José Sánchez; Miren Dorronsoro; Carmen Navarro; Aurelio Barricarte; Timothy J Key; Antonia Trichopoulou; Christos Tsironis; Pagona Lagiou; Giovanna Masala; Valeria Pala; Rosario Tumino; Paolo Vineis; Salvatore Panico; H Bas Bueno-de-Mesquita; Peter D Siersema; Bodil Ohlsson; Karin Jirström; Maria Wennberg; Lena M Nilsson; Elisabete Weiderpass; Tilman Kühn; Verena Katzke; Kay-Tee Khaw; Nick J Wareham; Anne Tjønneland; Heiner Boeing; José R Quirós; Marc J Gunter; Elio Riboli; Teresa Norat
Journal:  BMC Med       Date:  2015-05-07       Impact factor: 8.775

8.  Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.

Authors:  Anne Mette Falstie-Jensen; Anders Kjærsgaard; Ebbe Laugaard Lorenzen; Jeanette Dupont Jensen; Kristin Valborg Reinertsen; Olaf M Dekkers; Marianne Ewertz; Deirdre P Cronin-Fenton
Journal:  Breast Cancer Res       Date:  2019-03-22       Impact factor: 6.466

9.  Survivorship care plans for breast cancer patients: understanding the quality of the available evidence.

Authors:  V D'Souza; H Daudt; A Kazanjian
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

10.  A novel approach for discovering condition-specific correlations of gene expressions within biological pathways by using cloud computing technology.

Authors:  Tzu-Hao Chang; Shih-Lin Wu; Wei-Jen Wang; Jorng-Tzong Horng; Cheng-Wei Chang
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.